Bentham Science Logo

CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 19, 10 Issues, 2020
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

CNS & Neurological Disorders - Drug Targets , Volume 18 - Number 9


Review Article

The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer’s Disease: A Review

, 18(9): 657 - 667

Syed S. Ahmad*, Shahzad Khan, Mohammad A. Kamal and Umam Wasi


DOI: 10.2174/1871527318666191011145941



Review Article


Review Article (Mini-Review)

Childhood Hypertension and Effects on Cognitive Functions: Mechanisms and Future Perspectives

, 18(9): 677 - 686

Emma Tyner, Marie Oropeza, Johnny Figueroa and Ike C. dela Peña*


DOI: 10.2174/1871527318666191017155442



Review Article (Mini-Review)

Gut Microbiome: Lactation, Childbirth, Lung Dysbiosis, Animal Modeling, Stem Cell Treatment, and CNS Disorders

, 18(9): 687 - 694

Sydney Corey, Lauren Kvederis, Chase Kingsbury, Brooke Bonsack, Paul R. Sanberg, Vanessa Castelli, Jea-Young Lee and Cesar V. Borlongan*


DOI: 10.2174/1871527318666191021145252



Research Article


Research Article

Cannabidiol Partially Blocks the Excessive Sleepiness in Hypocretindeficient Rats: Preliminary Data

, 18(9): 705 - 712

Eric Murillo-Rodríguez*, Diana Millán-Aldaco, Marcela Palomero-Rivero, Daniela Morales-Lara, Raphael Mechoulam and René Drucker-Colín


DOI: 10.2174/1871527318666191021143300



Research Article

Combined Ischemic Preconditioning and Resveratrol Improved Bloodbrain Barrier Breakdown via Hippo/YAP/TAZ Signaling Pathway

, 18(9): 713 - 722

Ganji Hong, Ying Yan, Yali Zhong, Jianer Chen, Fei Tong and Qilin Ma*


DOI: 10.2174/1871527318666191021144126



Research Article

The Potential of Serratiopetidase and Lumbrokinase for the Degradation of Prion Peptide 106-126 - an In Vitro and In Silico Perspective

, 18(9): 723 - 731

Sanjay Kisan Metkar, Suparna Ghosh, Agnishwar Girigoswami and Koyeli Girigoswami*


DOI: 10.2174/1871527318666191021150002





Editor-in-Chief

Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL
USA

Biography View Full Editorial Board

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog